scholarly journals Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants

Author(s):  
Brian A Darlow ◽  
P J Graham ◽  
Maria Ximena Rojas-Reyes
PEDIATRICS ◽  
2009 ◽  
Vol 124 (4) ◽  
pp. 1009-1020 ◽  
Author(s):  
K. L. Peters ◽  
R. J. Rosychuk ◽  
L. Hendson ◽  
J. J. Cote ◽  
C. McPherson ◽  
...  

2015 ◽  
Vol 175 (3) ◽  
pp. 365-372 ◽  
Author(s):  
Bettina Schmiedchen ◽  
Ann Carolin Longardt ◽  
Andrea Loui ◽  
Christoph Bührer ◽  
Jens Raila ◽  
...  

2007 ◽  
Vol 96 (9) ◽  
pp. 1296-1302 ◽  
Author(s):  
Anne K Aurvåg ◽  
Christine Henriksen ◽  
Christian A Drevon ◽  
Per O Iversen ◽  
Britt Nakstad

Author(s):  
Alexis Hisey ◽  
Srinandini Sakhamuru ◽  
Thea Tagliaferro ◽  
Lorayne Barton ◽  
Rangasamy Ramanathan ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (7) ◽  
pp. e0131976 ◽  
Author(s):  
Hung-Yang Chang ◽  
Yi-Hsiang Sung ◽  
Shwu-Meei Wang ◽  
Hou-Ling Lung ◽  
Jui-Hsing Chang ◽  
...  

PEDIATRICS ◽  
1992 ◽  
Vol 89 (2) ◽  
pp. 357-357
Author(s):  
HELEN HARRISON

To the Editor.— The authors of the National Institute of Child Health and Human Development report on neonatal care1 found "important" variations among neonatal intensive care units in philosophies of treatment, methods of treatment, and short-term outcomes. In a recent meta-analysis of follow-up studies,2 researchers document a similarly haphazard approach to the long-term evaluation of very low birth weight survivors. Until randomized controlled clinical trials validate the safety and efficacy of neonatal therapies, and until long-term outcomes are assessed accurately, the treatment of very low birth weight infants should be declared experimental.


Sign in / Sign up

Export Citation Format

Share Document